Basic Information
| LncRNA/CircRNA Name | LINC00152 |
| Synonyms | CYTOR, C2orf59, LINC00152, NCRNA00152 |
| Region | GRCh38_2:87454781-87636740 |
| Ensemble | ENSG00000222041 |
| Refseq | NR_024204 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hemangioma |
| ICD-0-3 | NA |
| Methods | qPCR |
| Sample | hemangioma tissues,cell line |
| Expression Pattern | up-regulated |
| Function Description | Linc00152 was overexpressed in the proliferating-phase hemangioma tissues when compared with that in involuting-phase. |
| Pubmed ID | 31542613 |
| Year | 2019 |
| Title | Long non-coding RNA 00152 slicing represses the growth and aggressiveness of hemangioma cell by modulating miR-139-5p. |
External Links
| Links for LINC00152 | GenBank HGNC NONCODE |
| Links for hemangioma | OMIM COSMIC |